Results 281 to 290 of about 112,049 (293)

Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients

Lancet, The, 2001
exaly  

Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis

Circulation, 2017
Mesut Eren, Sadiya S Khan, Sweta Gupta
exaly  

[Plasminogen activator inhibitor 1 (PAI-1)].

Nihon rinsho. Japanese journal of clinical medicine, 1999
openaire   +2 more sources

Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

New England Journal of Medicine, 2000
exaly  

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

Diabetologia, 1991
exaly  

Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor

Cell, 1982
exaly  

Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes

Circulation, 1996
exaly  

Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction

New England Journal of Medicine, 1985
exaly  

Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/NG-Nitro-l-Arginine Methyl Ester-Induced Myocardial Injury

Circulation, 2003
exaly  

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

Lancet, The, 1992
exaly